Motley Fool Money Stock of the Week: Alcidion (June 30, 2021)
Jun 30, 2021
Kate Lee, a Motley Fool analyst who covers company research and stock picks, breaks down Alcidion, a healthcare software provider. She explains its hospital informatics platform and expansion in the UK. Conversations cover healthcare digitisation trends, Alcidion’s market positioning and growth avenues, plus the key risks around contracts and cash flow.
AI Snips
Chapters
Transcript
Episode notes
Alcidion Is A Public Health Software Provider
- Alcidion builds healthcare software platforms used by public health systems to improve clinical decision making and patient flow.
- Kate Lee says their products target hospitals in Australia, New Zealand and now expanding into the UK acute-care market.
Digitisation And Care Shift Create Strong Tailwinds
- Two structural trends drive demand: digitisation of health records and shifting delivery of care outside hospitals.
- Kate Lee argues those trends create a long-term tailwind for platforms that manage clinical workflows and home-based care.
UK Expansion Is The Major Growth Opportunity
- The UK market is materially larger than Australia and presents major expansion potential for Alcidion.
- Kate Lee cites a UK product market of about $1.1 billion versus $500 million in Australia and growing NHS trust penetration.